AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 11390726
Drug: Iron sucrose
RxNorm normalized name: Iron Sucrose
DrugBank: Iron sucrose (DB09146)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iron sucrose (250 mg iron diluted in 100 ml normal saline given over 60 min once per month)
Trial: 11390726
Drug: Iron gluconate
RxNorm normalized name: Iron Gluconate 27mg Tablet
DrugBank: Ferrous gluconate (DB14488)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iron gluconate (62.5 mg iron given once per week in a slow push injection)
Trial: 9422429
Drug: Prophylactic oral
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic oral ganciclovir (1000 mg p.o. t.i.d.; n=19)
Trial: 9422429
Drug: Deferred therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferred therapy (Acyclovir 200 mg p.o. b.i.d.; n=23)
Trial: 8388275
Drug: Rhesus-human reassortant
RxNorm normalized name: human-bovine reassortant rotavirus strain G4 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhesus-human reassortant tetravalent rotavirus vaccine (4 x 10^4 plaque forming units)
Trial: 8388275
Drug: Rhesus-human reassortant
RxNorm normalized name: human-bovine reassortant rotavirus strain G4 vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rhesus-human reassortant tetravalent rotavirus vaccine
Trial: 2834480
Drug: PK 10169
RxNorm normalized name: Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PK 10169 at 0.75 mg/kg
Trial: 2834480
Drug: PK 10169
RxNorm normalized name: Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PK 10169 at 1 mg/kg
Trial: 2834480
Drug: PK 10169
RxNorm normalized name: Pack
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PK 10169 at 1.25 mg/kg
Trial: 23614849
Drug: Diuretic added
RxNorm normalized name: Stahist AD
DrugBank: Chlorcyclizine (DB08936)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diuretic added during first month
Trial: 19095506
Drug: Ketamine-clonidine infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine-clonidine infusion before anesthesia induction
Trial: 12972745
Drug: Intravenous meperidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous meperidine analgesia
Trial: 7038157
Drug: Propranolol (180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (180 or 240 mg/day)
Trial: 28648913
Drug: Oxycodone (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (10 mg extended release b.i.d)
Trial: 28648913
Drug: Venlafaxine (37.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Venlafaxine (37.5 mg extended release b.i.d)
Trial: 26556692
Drug: One year
RxNorm normalized name: Annovera 0.15 MG / 0.013 MG per 24HR One Year Vaginal System
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One year of free school fruit (daily one piece of fruit or vegetable)
Trial: 19894656
Drug: Treatment based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment based on first visit
Trial: 14628989
Drug: Paroxetine (any
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine (any dose)
Trial: 11405344
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human alpha‐Gal A (r‐halphaGal A) replacement therapy for Fabry disease
Trial: 9404906
Drug: Cefixime (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefixime (10 mg/kg to 12 mg/kg per day in two divided doses)
Trial: 9404906
Drug: Chloramphenicol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloramphenicol (100 mg/kg daily in four divided doses)
Trial: 8388231
Drug: Chemotherapy plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy plus verapamil (480 mg day‐1 for 3 days prior to chemotherapy)
Trial: 3317054
Drug: Methylprednisolone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (30 mg/kg every six hours for 24 hours)
Trial: 28838583
Drug: Oral Aripiprazole
RxNorm normalized name: Aripiprazole
DrugBank: Aripiprazole (DB01238)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Oral Aripiprazole 10 to 30 mg/d
Trial: 26614965
Drug: PrEP with
RxNorm normalized name: Alcohol Prep with Benzocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PrEP with oral emtricitabine and tenofovir disoproxil fumarate
Trial: 23335369
Drug: R-CHOP treatment
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-CHOP treatment with MYC, BCL2, and BCL6 rearrangements and protein expression analysis
Trial: 21569539
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no anti-epileptic drugs)
Trial: 16543098
Drug: Low-dose intrathecal
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose intrathecal morphine (0.2 mg)
Trial: 14597934
Drug: β-blocker therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-blocker therapy for CHF
Trial: 10912311
Drug: Non-hormonal and
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Non-hormonal and hormonal agents
Trial: 9238868
Drug: Braun Oral‐B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Braun Oral‐B Interclean (ID2)
Trial: 29867230
Drug: Atezolizumab (monotherapy)
RxNorm normalized name: Atezolizumab
DrugBank: Atezolizumab (DB11595)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Atezolizumab (monotherapy)
Trial: 25990196
Drug: Focal muscle
RxNorm normalized name: ActivOn Joint & Muscle
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Focal muscle vibration (FMV) treatment according to the 'repeated muscle vibration' protocol
Trial: 19058081
Drug: Helix aspersa
RxNorm normalized name: Helix aspersa specific immunoglobulin E
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Helix aspersa extract cream applied twice daily for a maximum period of 14 days or until full epithelialization
Trial: 19058081
Drug: Moist exposure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moist exposure burn ointment (MEBO)
Trial: 15643550
Drug: BSE-018 with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BSE-018 with a high-fat meal (treatment B)
Trial: 15643550
Drug: BSE-018 in
RxNorm normalized name: NUTR SUPL COMPLEAT ORGANIC PLANT BSE LIQ
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BSE-018 in the fasted state (treatment A)
Trial: 11441425
Drug: Butorphanol (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Butorphanol (0.5, 1, and 2 mg/70 kg)
Trial: 11441425
Drug: Morphine (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (2.5, 5, and 10 mg/70 kg)
Trial: 11441425
Drug: Nalbuphine (2.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine (2.5, 5, and 10 mg/70 kg)
Trial: 11441425
Drug: Pentazocine (7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pentazocine (7.5 and 15 mg/70 kg)
Trial: 9075778
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) 350 mg/m2 as intravenous bolus injection plus folinic acid (FA) 200 mg/m2 and interferon 5 x 10(6) U/m2 (regimen A)
Trial: 9075778
Drug: 5-fluorouracil (5-FU)
RxNorm normalized name: 5-FU
DrugBank: Fluorouracil (DB00544)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 5-fluorouracil (5-FU) 500 mg/m2 as 2-hour infusion plus folinic acid (FA) 200 mg/m2 and interferon 5 x 10(6) U/m2 (regimen B)
Trial: 16296710
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 mg once daily, adjusted to 10 mg after 2 weeks if necessary)
Trial: 7019407
Drug: Oxacillin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxacillin plus sisomicin and carbenicillin (treatment group)
Trial: 30378465
Drug: High-dose caffeine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose caffeine (10 mg/kg)
Trial: 30378465
Drug: Moderate-dose caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Moderate-dose caffeine (4 mg/kg)
Trial: 30378465
Drug: Repeated-dose caffeine
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated-dose caffeine (2 mg/kg before each match to a total of 10 mg/kg)
Trial: 30378465
Drug: Selective caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Selective caffeine administration (6.16 ± 1.58 mg/kg)
Trial: 30202508
Drug: Human agent
RxNorm normalized name: Insulin Human
DrugBank: Insulin human (DB00030)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Human agent intervention
Trial: 23797624
Drug: Clonidine 1
RxNorm normalized name: apraclonidine 10 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 1 μg/kg added to 2% lidocaine
Trial: 20565999
Drug: Normal protein,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal protein, glycogen-lowering exercise (NP-g; 10, 60 and 30 En%)
Trial: 20565999
Drug: High protein,
RxNorm normalized name: Ensure High Protein, Banana, Instant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High protein, carbohydrate-free (HP-0C) vs Normal protein (NP-g)
Trial: 17629719
Drug: r-metHuGDNF via
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: r-metHuGDNF via continuous bilateral intraputaminal infusion
Trial: 12805964
Drug: Quinfamide treatment
RxNorm normalized name: quinfamide
DrugBank: Quinfamide (DB12780)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quinfamide treatment (4.3 g/kg dose) administered at 3- or 6-month intervals.
Trial: 9764615
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (50 microg every 4 hours)
Trial: 9764615
Drug: Oral and
RxNorm normalized name: Tridate, oral and rectal kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral and Vaginal misoprostol
Trial: 8181333
Drug: Nebulized ipratropium
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nebulized ipratropium bromide added to albuterol sulfate
Trial: 6831946
Drug: Albuterol alone
RxNorm normalized name: Albuterol
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol alone
Trial: 30393104
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) at doses of 50 mg, 75 mg, and 100 mg, with training (reviewed IFU and shown how to inject)
Trial: 30393104
Drug: Testosterone enanthate
RxNorm normalized name: Testosterone Enanthate
DrugBank: Testosterone enanthate (DB13944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Testosterone enanthate (TE) at doses of 50 mg, 75 mg, and 100 mg, without training (only given IFU)
Trial: 24781225
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment with antidepressants and antipsychotics
Trial: 22835841
Drug: Extinction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extinction treatment in three contexts (BCD)
Trial: 22835841
Drug: Extinction treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extinction treatment in one context (B)
Trial: 20555288
Drug: Estrogen +
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen + Testosterone (40 mg testosterone undecanoate)
Trial: 18482290
Drug: DHEA supplementation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DHEA supplementation (50 mg daily for 1 year)
Trial: 10501246
Drug: Intranasal vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal vaccine composed of native outer membrane vesicles (NOMV)
Trial: 28590525
Drug: Repeated injections
RxNorm normalized name: eicosyl povidone (2 eicosyl branches-repeat)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Repeated injections of abobotulinumtoxinA
Trial: 27039205
Drug: White wine
RxNorm normalized name: White wine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: White wine with ≤15% alcohol content twice a day for 3-4 weeks
Trial: 27039205
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement (such as Boost® or Ensure®)
Trial: 24413342
Drug: Mindfulness treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness treatment
Trial: 21122516
Drug: Oral plus
RxNorm normalized name: Acetaminophen/Dexbrompheniramine Maleate/Pseudoephedrine Hydrochloride 500 MG-3 MG-60 MG Oral Tablet, Extended Release [DRIXORAL PLUS]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral plus enema mesalazine treatment (PINCE)
Trial: 21122516
Drug: Oral mesalazine
RxNorm normalized name: mesalamine Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral mesalazine treatment alone (Control)
Trial: 16269638
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus thermal stimulation (TS) for 30 minutes daily for 6 weeks
Trial: 16269638
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment plus thermal stimulation (TS)
Trial: 12412828
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of mycophenolate mofetil alone (treatment 1)
Trial: 12412828
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of mycophenolate mofetil and 2400 mg of calcium polycarbophil (treatment 2)
Trial: 12412828
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of mycophenolate mofetil and 2400 mg of calcium polycarbophil with 30 mg of lansoprazole for 5 days (treatment 3)
Trial: 9706948
Drug: Tramadol (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tramadol (1.25 mg/kg)
Trial: 9706948
Drug: Morphine (0.125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.125 mg/kg)
Trial: 312297
Drug: salsalate (salicylsalicylic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: salsalate (salicylsalicylic acid) 3000 mg
Trial: 312297
Drug: aspirin 3900
RxNorm normalized name: aspirin 3900 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: aspirin 3900 mg
Trial: 19337257
Drug: Immunochemical faecal
RxNorm normalized name: Enterococcus faecalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunochemical faecal occult blood testing (FIT) at cut-off 75 ng/ml
Trial: 19337257
Drug: Immunochemical faecal
RxNorm normalized name: Enterococcus faecalis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunochemical faecal occult blood testing (FIT) at varying cut-off levels (50-200 ng/ml)
Trial: 3521767
Drug: Adjuvant tamoxifen,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant tamoxifen, 40 mg daily for three years
Trial: 30307466
Drug: Letrozole (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole (2.5 mg daily) and palbociclib (125 mg daily, 3 weeks/4) during 19 weeks
Trial: 30307466
Drug: Chemotherapy (FEC100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy (FEC100 followed by docetaxel)
Trial: 26454185
Drug: Behavioral activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Behavioral activation (5 weekly sessions)
Trial: 25391006
Drug: RBV for
RxNorm normalized name: RBV
DrugBank: Ribavirin (DB00811)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: RBV for 4 weeks followed by combined therapy with peg‐IFN alpha‐2a + RBV for 48 weeks (n = 73)
Trial: 25391006
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy with peg‐IFN alpha‐2a + RBV for 48 weeks (n = 30)
Trial: 20844613
Drug: Intracoronary infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary infusion of 150 × 10^6 autologous bone marrow mononuclear cells
Trial: 16012273
Drug: SNRI antidepressants
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SNRI antidepressants
Trial: 12651759
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid tablets (Aminogran Food Supplement, UCB)
Trial: 12651759
Drug: Amino acid
RxNorm normalized name: Amino Acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amino acid tablets
Trial: 10820174
Drug: Furosemide 120
RxNorm normalized name: furosemide 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 120 mg alone
Trial: 10820174
Drug: Furosemide 120
RxNorm normalized name: furosemide 120 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 120 mg plus sulfisoxazole
Trial: 6151343
Drug: Prizidilol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prizidilol (200 mg X 2)
Trial: 6151343
Drug: Carvedilol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (25 mg and 50 mg)
Trial: 6151343
Drug: Carvedilol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (25 mg X 2 and 50 mg X 2)
Trial: 1350491
Drug: Carvedilol (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (50 mg)
Trial: 6151343
Drug: Prizidilol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prizidilol (400 mg)
Trial: 21730017
Drug: SB-649868 (10-80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-649868 (10-80 mg single dose)
Trial: 21730017
Drug: SB-649868 (5-30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-649868 (5-30 mg multiple repeat dose)
Trial: 21730017
Drug: SB-649868 (evening
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SB-649868 (evening dosing)
Trial: 18946429
Drug: Thiopentone and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thiopentone and ketamine combination (Group III)
Trial: 17311602
Drug: Ipratropium 40
RxNorm normalized name: Ipratropium
DrugBank: Ipratropium (DB00332)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ipratropium 40 microg by inhalation (positive control)
Trial: 17311602
Drug: Oral loperamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral loperamide 4 mg
Trial: 11294513
Drug: Percutaneous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous estradiol gel 1.25 g (0.75 mg E2)
Trial: 11294513
Drug: Percutaneous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous estradiol gel 2.5 g (1.5 mg E2)
Trial: 11294513
Drug: Percutaneous estradiol
RxNorm normalized name: Estradiol
DrugBank: Estradiol acetate (DB13952)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Percutaneous estradiol gel 0.625 g (0.375 mg E2)
Trial: 11294513
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol patch delivering 0.05 mg E2 per day
Trial: 9767555
Drug: Triple drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple drug immunosuppressive regimen including CsA, azathioprine and corticosteroids
Trial: 9767555
Drug: Quadruple sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadruple sequential combination of rabbit antithymocyte globulin (ATG) for 10 days, azathioprine, corticosteroids and delayed CsA
Trial: 7874660
Drug: Marital therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marital therapy alone
Trial: 7874660
Drug: Marital therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marital therapy in combination with antidepressants
Trial: 3396702
Drug: High-dosage testosterone
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dosage testosterone enanthate (TE) for 5 to 6 months
Trial: 3396702
Drug: Placebo (sesame
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (sesame oil) injections for 5 to 6 months
Trial: 30791735
Drug: Yoga therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yoga therapy (60 minutes once a week for 8 weeks)
Trial: 24060261
Drug: Arthritis-specific demographics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Arthritis-specific demographics (type, medication use)
Trial: 24060261
Drug: Older age,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Older age, less than a high school education, rheumatoid arthritis, greater arthritis duration, taking steroids, taking narcotics, greater pain, greater stiffness, greater depressive symptoms, lower arthritis self-efficacy
Trial: 21428240
Drug: Olanzapine film-coated
RxNorm normalized name: olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine film-coated tablet (test formulation)
Trial: 21428240
Drug: Olanzapine orodispersible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Olanzapine orodispersible tablet (test formulation)
Trial: 21428240
Drug: Reference formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulations (brand formulations)
Trial: 11963648
Drug: Lidose formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidose formulation of fenofibrate (67 mg)
Trial: 11963648
Drug: Lidose formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidose formulation of fenofibrate (200 mg)
Trial: 11963648
Drug: Reference micronized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference micronized formulation of fenofibrate (67 mg)